SMN2 and proximal spinal muscular atrophy: Another potential drug has been thus far tested in vivo and shown to ameliorate symptoms of SMA in mice by a moderate increase of SMN2 production as a result of targeting a 3′ arm of a long-distance structure located deep within an intron 7 [259].